Are mast cells instrumental for fibrotic diseases?

Frontiers in Pharmacology

Volumn 4 JAN, Issue , 2014, Pages

  Overed Sayer, Catherine ^a   Rapley, Laura ^a   Mustelin, Tomas ^a   Clarke, Deborah L ^a  

^a MEDIMMUNE   (United States)

Author keywords

Fibrosis; Idiopathic pulmonary fibrosis; Lung; Mast cells; TGF

Indexed keywords

CHYMASE; INTERLEUKIN 13; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE;

ASTHMA; ATOPIC DERMATITIS; CYTOLOGY; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; HEALING; HUMAN; IMMUNOPATHOGENESIS; KIDNEY FIBROSIS; MAST CELL; MEDIATOR RELEASE; NONHUMAN; REVIEW; TISSUE REMODELING; TISSUE REPAIR;

EID: 84893745158     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00174     Document Type: Review

References (136)

1. Abraham, S. N., and St John, A. L. (2010). Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10, 440-452. doi: 10.1038/nri2782.
2. Akers, I. A., Parsons, M., Hill, M. R., Hollenberg, M. D., Sanjar, S., Laurent, G. J., et al. (2000). Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L193-L201.
3. Andersson, C. K., Andersson-Sjoland, A., Mori, M., Hallgren, O., Pardo, A., Eriksson, L., et al. (2011a). Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis. Respir. Res. 12, 139. doi: 10.1186/1465-9921-12-139.
4. Andersson, C. K., Bergqvist, A., Mori, M., Mauad, T., Bjermer, L., and Erjefalt, J. S. (2011b). Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. J. Allergy Clin. Immunol. 127, 905-912. doi: 10.1016/j.jaci.2011.01.022.
5. Andersson, C. K., Mori, M., Bjermer, L., Lofdahl, C. G., and Erjefalt, J. S. (2009). Novel site-specific mast cell subpopulations in the human lung. Thorax 64, 297-305. doi: 10.1136/thx.2008.101683.
6. Antsiferova, M., Martin, C., Huber, M., Feyerabend, T. B., Forster, A., Hartmann, K., et al. (2013). Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis. J. Immunol. 191, 6147-6155. doi: 10.4049/jimmunol.1301350.
7. Arinobu, Y., Iwasaki, H., Gurish, M. F., Mizuno, S., Shigematsu, H., Ozawa, H., et al. (2005). Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 102, 18105-18110. doi: 10.1073/pnas.0509148102.
8. Artuc, M., Hermes, B., Steckelings, U. M., Grutzkau, A., and Henz, B. M. (1999). Mast cells and their mediators in cutaneous wound healing: active participants or innocent bystanders? Exp. Dermatol. 8, 1-16. doi: 10.1111/j.1600-0625.1999.tb00342.x.
9. Artuc, M., Steckelings, U. M., and Henz, B. M. (2002). Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J. Invest. Dermatol. 118, 391-395. doi: 10.1046/j.0022-202x.2001.01705.x.
10. Austen, K. F., and Boyce, J. A. (2001). Mast cell lineage development and phenotypic regulation. Leuk. Res. 25, 511-518. doi: 10.1016/S0145-2126(01)00030-3.
11. Balzar, S., Fajt, M. L., Comhair, S. A., Erzurum, S. C., Bleecker, E., Busse, W. W., et al. (2011). Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 183, 299-309. doi: 10.1164/rccm.201002-0295OC.
12. Berres, M. L., Koenen, R. R., Rueland, A., Zaldivar, M. M., Heinrichs, D., Sahin, H., et al. (2010). Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J. Clin. Invest. 120, 4129-4140. doi: 10.1172/JCI41732.
13. Black, J. L., Burgess, J. K., and Johnson, P. R. (2003). Airway smooth muscle: its relationship to the extracellular matrix. Respir. Physiol. Neurobiol. 137, 339-346. doi: 10.1016/S1569-9048(03)00157-5.
14. Boyce, J. A. (2005). Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem. Immunol. Allergy 87, 59-79. doi: 10.1159/000087571.
15. Bradding, P., Okayama, Y., Howarth, P. H., Church, M. K., and Holgate, S. T. (1995). Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155, 297-307.
16. Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., and Pavord, I. D. (2002). Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346, 1699-1705. doi: 10.1056/NEJMoa012705.
17. Brown, J. K., Tyler, C. L., Jones, C. A., Ruoss, S. J., Hartmann, T., and Caughey, G. H. (1995). Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13, 227-236. doi: 10.1165/ajrcmb.13.2.7626290.
18. Burd, P. R., Rogers, H. W., Gordon, J. R., Martin, C. A., Jayaraman, S., Wilson, S. D., et al. (1989). Interleukin 3-dependent and-independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170, 245-257. doi: 10.1084/jem.170.1.245.
19. Burd, P. R., Thompson, W. C., Max, E. E., and Mills, F. C. (1995). Activated mast cells produce interleukin 13. J. Exp. Med. 181, 1373-1380. doi: 10.1084/jem.181.4.1373.
20. Cairns, J. A., and Walls, A. F. (1996). Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J. Immunol. 156, 275-283.
21. Cairns, J. A., and Walls, A. F. (1997). Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 99, 1313-1321. doi: 10.1172/JCI119290.
22. Cevikbas, F., and Steinhoff, M. (2012). IL-33: a novel danger signal system in atopic dermatitis. J. Invest. Dermatol. 132, 1326-1329. doi: 10.1038/jid.2012.66.
23. Cha, S. I., Chang, C. S., Kim, E. K., Lee, J. W., Matthay, M. A., Golden, J. A., et al. (2012). Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis. Histopathology 61, 98-106. doi: 10.1111/j.1365-2559.2012.04197.x.
24. Chen, C. C., Grimbaldeston, M. A., Tsai, M., Weissman, I. L., and Galli, S. J. (2005). Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. U.S.A. 102, 11408-11413. doi: 10.1073/pnas.0504197102.
25. Chitra, P., Saiprasad, G., Manikandan, R., and Sudhandiran, G. (2013). Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kappaB dependant TGF-beta activation: a biphasic experimental study. Toxicol. Lett. 219, 178-193. doi: 10.1016/j.toxlet.2013.03.009.
26. Clarke, D. L., Carruthers, A. M., Mustelin, T., and Murray, L. A. (2013). Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Fibrogenesis Tissue Repair 6, 20. doi: 10.1186/1755-1536-6-20.
27. Darsow, U., Pfab, F., Valet, M., Tolle, T. R., and Ring, J. (2012). Itch and eczema. Chem. Immunol. Allergy 96, 81-88. doi: 10.1159/000331890.
28. Dempsey, O. J. (2006). Clinical review: idiopathic pulmonary fibrosis: past, present and future. Respir. Med. 100, 1871-1885. doi: 10.1016/j.rmed.2006.08.017.
29. Desmouliere, A., Geinoz, A., Gabbiani, F., and Gabbiani, G. (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122, 103-111. doi: 10.1083/jcb.122.1.103.
30. Ding, L., Dolgachev, V., Wu, Z., Liu, T., Nakashima, T., Wu, Z., et al. (2013). Essential role of stem cell factor-c-kit remodeling pathway in bleomycin-induced pulmonary fibrosis. J. Pathol. 230, 205-214. doi: 10.1002/path.4177.
31. Dolgachev, V. A., Ullenbruch, M. R., Lukacs, N. W., and Phan, S. H. (2009). Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. Am. J. Pathol. 174, 390-400. doi: 10.2353/ajpath.2009.080513.
32. Domen, J., and Weissman, I. L. (2000). Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J. Exp. Med. 192, 1707-1718. doi: 10.1084/jem.192.12.1707.
33. Dougherty, R. H., Sidhu, S. S., Raman, K., Solon, M., Solberg, O. D., Caughey, G. H., et al. (2010). Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J. Allergy Clin. Immunol. 125, 1046-1053. doi: 10.1016/j.jaci.2010.03.003.
34. Dvorak, A. M. (2005). Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle. Chem. Immunol. Allergy 85, 185-204. doi: 10.1159/000086517.
35. Edwards, S. T., Cruz, A. C., Donnelly, S., Dazin, P. F., Schulman, E. S., Jones, K. D., et al. (2005). C-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. J. Pathol. 206, 279-290. doi: 10.1002/path.1780.
36. Egozi, E. I., Ferreira, A. M., Burns, A. L., Gamelli, R. L., and Dipietro, L. A. (2003). Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen. 11, 46-54. doi: 10.1046/j.1524-475X.2003.11108.x.
37. Enoksson, M., Lyberg, K., Moller-Westerberg, C., Fallon, P. G., Nilsson, G., and Lunderius-Andersson, C. (2011). Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 186, 2523-2528. doi: 10.4049/jimmunol.1003383.
38. Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., and Kitani, A. (2006). IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 12, 99-106. doi: 10.1038/nm1332.
39. Fine, A., and Goldstein, R. H. (1987). The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 262, 3897-3902.
40. Fireman, E., Kivity, S., Shahar, I., Reshef, T., and Mekori, Y. A. (1999). Secretion of stem cell factor by alveolar fibroblasts in interstitial lung diseases. Immunol. Lett. 67, 229-236. doi: 10.1016/S0165-2478(99)00020-6.
41. Firszt, R., Francisco, D., Church, T. D., Thomas, J. M., Ingram, J. L., and Kraft, M. (2013). Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-beta1 in airway fibroblasts in asthma. Eur. Respir. J. doi: 10.1183/09031936.00068712 [Epub ahead of print].
42. Fleming, W. H., Alpern, E. J., Uchida, N., Ikuta, K., and Weissman, I. L. (1993). Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 90, 3760-3764. doi: 10.1073/pnas.90.8.3760.
43. Fortoul, T. I., and Barrios, R. (1990). Mast cells and idiopathic lung fibrosis. Arch. Invest. Med. 21, 5-10.
44. Franco, C. B., Chen, C. C., Drukker, M., Weissman, I. L., and Galli, S. J. (2010). Distinguishing mast cell and granulocyte differentiation at the single-cell level. Cell Stem Cell 6, 361-368. doi: 10.1016/j.stem.2010.02.013.
45. Frieling, T., Meis, K., Kolck, U. W., Homann, J., Hulsdonk, A., Haars, U., et al. (2011). Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z. Gastroenterol. 49, 191-194. doi: 10.1055/s-0029-1245707.
46. Gallant-Behm, C. L., Hildebrand, K. A., and Hart, D. A. (2008). The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs. Wound Repair Regen. 16, 226-233. doi: 10.1111/j.1524-475X.2008.00363.x.
47. Gibson, P. G., Allen, C. J., Yang, J. P., Wong, B. J., Dolovich, J., Denburg, J., et al. (1993). Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am. Rev. Respir. Dis. 148, 80-86. doi: 10.1164/ajrccm/148.1.80.
48. Gilfillan, A. M., and Beaven, M. A. (2011). Regulation of mast cell responses in health and disease. Crit. Rev. Immunol. 31, 475-529. doi: 10.1615/CritRevImmunol.v31.i6.30.
49. Goldstein, S. M., Leong, J., Schwartz, L. B., and Cooke, D. (1992). Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J. Immunol. 148, 2475-2482.
50. Gordon, J. R., and Galli, S. J. (1990). Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346, 274-276. doi: 10.1038/346274a0.
51. Greaves, M. W., and Khalifa, N. (2004). Itch: more than skin deep. Int. Arch. Allergy Immunol. 135, 166-172. doi: 10.1159/000080898.
52. Gruber, B. L., Kew, R. R., Jelaska, A., Marchese, M. J., Garlick, J., Ren, S., et al. (1997). Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 158, 2310-2317.
53. Gurish, M. F., and Austen, K. F. (2012). Developmental origin and functional specialization of mast cell subsets. Immunity 37, 25-33. doi: 10.1016/j.immuni.2012.07.003.
54. Haenisch, B., Nothen, M. M., and Molderings, G. J. (2012). Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunology 137, 197-205. doi: 10.1111/j.1365-2567.2012.03627.x.
55. Hamid, Q., Boguniewicz, M., and Leung, D. Y. (1994). Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94, 870-876. doi: 10.1172/JCI117408.
56. Hogan, A. D., and Schwartz, L. B. (1997). Markers of mast cell degranulation. Methods 13, 43-52. doi: 10.1006/meth.1997.0494.
57. Holdsworth, S. R., and Summers, S. A. (2008). Role of mast cells in progressive renal diseases. J. Am. Soc. Nephrol. 19, 2254-2261. doi: 10.1681/ASN.2008010015.
58. Holgate, S. T. (2008). Pathogenesis of asthma. Clin. Exp. Allergy 38, 872-897. doi: 10.1111/j.1365-2222.2008.02971.x.
59. Hollins, F., Kaur, D., Yang, W., Cruse, G., Saunders, R., Sutcliffe, A., et al. (2008). Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. J. Immunol. 181, 2772-2780.
60. Howarth, P. H., Knox, A. J., Amrani, Y., Tliba, O., Panettieri, R. A. Jr., and Johnson, M. (2004). Synthetic responses in airway smooth muscle. J. Allergy Clin. Immunol. 114, S32-S50. doi: 10.1016/j.jaci.2004.04.041.
61. Hunt, L. W., Colby, T. V., Weiler, D. A., Sur, S., and Butterfield, J. H. (1992). Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin. Proc. 67, 941-948. doi: 10.1016/S0025-6196(12)60924-0.
62. Iba, Y., Shibata, A., Kato, M., and Masukawa, T. (2004). Possible involvement of mast cells in collagen remodeling in the late phase of cutaneous wound healing in mice. Int. Immunopharmacol. 4, 1873-1880. doi: 10.1016/j.intimp.2004.08.009.
63. Iddamalgoda, A., Le, Q. T., Ito, K., Tanaka, K., Kojima, H., and Kido, H. (2008). Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch. Dermatol. Res. 300(Suppl. 1), S69-S76. doi: 10.1007/s00403-007-0806-1.
64. Ingram, J. L., Rice, A. B., Geisenhoffer, K., Madtes, D. K., and Bonner, J. C. (2004). IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. FASEB J. 18, 1132-1134. doi: 10.1096/fj.03-1492fje.
65. Inoue, Y., King, T. E. Jr., Tinkle, S. S., Dockstader, K., and Newman, L. S. (1993). Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am. J. Pathol. 149, 2037-2054.
66. Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., and Schwartz, L. B. (1986). Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. U.S.A. 83, 4464-4468. doi: 10.1073/pnas.83.12.4464.
67. James, A., and Carroll, N. (2000). Airway smooth muscle in health and disease; methods of measurement and relation to function. Eur. Respir. J. 15, 782-789. doi: 10.1034/j.1399-3003.2000.15d25.x.
68. James, A. L., Elliot, J. G., Abramson, M. J., and Walters, E. H. (2005). Time to death, airway wall inflammation and remodelling in fatal asthma. Eur. Respir. J. 26, 429-434. doi: 10.1183/09031936.05.00146404.
69. Kanbe, N., Kurosawa, M., Nagata, H., Saitoh, H., and Miyachi, Y. (1999). Cord blood-derived human cultured mast cells produce transforming growth factor beta1. Clin. Exp. Allergy 29, 105-113. doi: 10.1046/j.1365-2222.1999.00459.x.
70. Kaur, D., Saunders, R., Berger, P., Siddiqui, S., Woodman, L., Wardlaw, A., et al. (2006). Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am. J. Respir. Crit. Care Med. 174, 1179-1188. doi: 10.1164/rccm.200603-394OC.
71. Kawanami, O., Ferrans, V. J., Fulmer, J. D., and Crystal, R. G. (1979). Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 40, 717-734.
72. Kawatani, K., Kondo, M., Tamaoki, J., Tagaya, E., and Nagai, A. (2007). [The clinical significance of mast cell tryptase in bronchial alveolar lavage fluid in interstitial lung diseases]. Nihon Kokyuki Gakkai Zasshi 45, 848-855.
73. Kay, A. B. (2005). The role of eosinophils in the pathogenesis of asthma. Trends Mol. Med. 11, 148-152. doi: 10.1016/j.molmed.2005.02.002.
74. Kitamura, Y., Hatanaka, K., Murakami, M., and Shibata, H. (1979). Presence of mast cell precursors in peripheral blood of mice demonstrated by parabiosis. Blood 53, 1085-1088.
75. Kondo, S., Kagami, S., Kido, H., Strutz, F., Muller, G. A., and Kuroda, Y. (2001). Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 12, 1668-1676.
76. Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., et al. (2001). Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809-821. doi: 10.1084/jem.194.6.809.
77. Levi-Schaffer, F., and Kupietzky, A. (1990). Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp. Cell Res. 188, 42-49. doi: 10.1016/0014-4827(90)90275-F.
78. Levi-Schaffer, F., and Piliponsky, A. M. (2003). Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol. 24, 158-161. doi: 10.1016/S1471-4906(03)00058-9.
79. Liu, H., Liu, F., Peng, Y., Liu, Y., Li, L., Tu, X., et al. (2010). Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy. Inflamm. Res. 59, 551-559. doi: 10.1007/s00011-010-0159-7.
80. Lowman, M. A., Rees, P. H., Benyon, R. C., and Church, M. K. (1988). Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J. Allergy Clin. Immunol. 81, 590-597. doi: 10.1016/0091-6749(88)90199-6.
81. Lucas, H. J., Brauch, C. M., Settas, L., and Theoharides, T. C. (2006). Fibromyalgia: new concepts of pathogenesis and treatment. Int. J. Immunopathol. Pharmacol. 19, 5-10.
82. Lukacs, N. W., Strieter, R. M., Chensue, S. W., and Kunkel, S. L. (1996). Activation and regulation of chemokines in allergic airway inflammation. J. Leukoc. Biol. 59, 13-17.
83. Manuyakorn, W., Howarth, P. H., and Holgate, S. T. (2013). Airway remodelling in asthma and novel therapy. Asian Pac. J. Allergy Immunol. 31, 3-10.
84. Mattoli, S., Ackerman, V., Vittori, E., and Marini, M. (1995). Mast cell chemotactic activity of RANTES. Biochem. Biophys. Res. Commun. 209, 316-321. doi: 10.1006/bbrc.1995.1505.
85. Metcalfe, D. D., Baram, D., and Mekori, Y. A. (1997). Mast cells. Physiol. Rev, 77, 1033-1079.
86. Metz, M., Piliponsky, A. M., Chen, C. C., Lammel, V., Abrink, M., Pejler, G., et al. (2006). Mast cells can enhance resistance to snake and honeybee venoms. Science 313, 526-530. doi: 10.1126/science.1128877.
87. Metz, M., Wahn, U., Gieler, U., Stock, P., Schmitt, J., and Blume-Peytavi, U. (2013). Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians. Pediatr. Allergy Immunol. 24, 527-539. doi: 10.1111/pai.12115.
88. Mori, H., Kawada, K., Zhang, P., Uesugi, Y., Sakamoto, O., and Koda, A. (1991). Bleomycin-induced pulmonary fibrosis in genetically mast cell-deficient WBB6F1-W/Wv mice and mechanism of the suppressive effect of tranilast, an antiallergic drug inhibiting mediator release from mast cells, on fibrosis. Int. Arch. Allergy Appl. Immunol. 95, 195-201. doi: 10.1159/000235429.
89. Moritz, D. R., Rodewald, H. R., Gheyselinck, J., and Klemenz, R. (1998). The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 161, 4866-4874.
90. Mukai, K., BenBarak, M. J., Tachibana, M., Nishida, K., Karasuyama, H., Taniuchi, I., et al. (2012). Critical role of P1-Runx1 in mouse basophil development. Blood 120, 76-85. doi: 10.1182/blood-2011-12-399113.
91. Nakamura, Y., Tajima, F., Ishiga, K., Yamazaki, H., Oshimura, M., Shiota, G., et al. (2004). Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Exp. Hematol. 32, 390-396. doi: 10.1016/j.exphem.2004.01.004.
92. Navaratnam, V., Fogarty, A. W., Glendening, R., McKeever, T., and Hubbard, R. B. (2013). The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010. Chest 143, 1078-1084. doi: 10.1378/chest.12-0803.
93. Noli, C., and Miolom, A. (2001). The mast cell in wound healing. Vet. Dermatol. 12, 303-313. doi: 10.1046/j.0959-4493.2001.00272.x.
94. Okazaki, T., Hirota, S., Xu, Z. D., Maeyama, K., Nakama, A., Kawano, S., et al. (1998). Increase of mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab. Invest. 78, 1431-1438.
95. Oliveira, S. H., and Lukacs, N. W. (2001). Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm. Res. 50, 168-174. doi: 10.1007/s000110050741.
96. Oriente, A., Fedarko, N. S., Pacocha, S. E., Huang, S. K., Lichtenstein, L. M., and Essayan, D. M. (2000). Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J. Pharmacol. Exp. Ther. 292, 988-994.
97. Page, S., Ammit, A. J., Black, J. L., and Armour, C. L. (2001). Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1313-L1323.
98. Pesci, A., Bertorelli, G., Gabrielli, M., and Olivieri, D. (1993). Mast cells in fibrotic lung disorders. Chest 103, 989-996. doi: 10.1378/chest.103.4.989.
99. Plaut, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., and Paul, W. E. (1989). Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339, 64-67. doi: 10.1038/339064a0.
100. Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., and Kang, A. H. (1987). Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J. Exp. Med. 165, 251-256. doi: 10.1084/jem.165.1.251.
101. Prefontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., et al. (2009). Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103. doi: 10.4049/jimmunol.0802387.
102. Qi, X., Hong, J., Chaves, L., Zhuang, Y., Chen, Y., Wang, D., et al. (2013). Antagonistic regulation by the transcription factors C/EBPalpha and MITF specifies basophil and mast cell fates. Immunity 39, 97-110. doi: 10.1016/j.immuni.2013.06.012.
103. Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., et al. (2011). An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788-824. doi: 10.1164/rccm.2009-040GL.
104. Rankin, J. A., Kaliner, M., and Reynolds, H. Y. (1987). Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis. J. Allergy Clin. Immunol. 79, 371-377. doi: 10.1016/0091-6749(87)90158-8.
105. Razin, E., Mencia-Huerta, J. M., Stevens, R. L., Lewis, R. A., Liu, F. T., Corey, E., et al. (1983). IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J. Exp. Med. 157, 189-201. doi: 10.1084/jem.157.1.189.
106. Reber, L. L., Marichal, T., and Galli, S. J. (2012). New models for analyzing mast cell functions in vivo. Trends Immunol. 33, 613-625. doi: 10.1016/j.it.2012.09.008.
107. Riley, J. F., and West, G. B. (1953). The presence of histamine in tissue mast cells. J. Physiol. (Lond.) 120, 528-537.
108. Rodewald, H. R., Dessing, M., Dvorak, A. M., and Galli, S. J. (1996). Identification of a committed precursor for the mast cell lineage. Science 271, 818-822. doi: 10.1126/science.271.5250.818.
109. Ruoss, S. J., Hartmann, T., and Caughey, G. H. (1991). Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88, 493-499. doi: 10.1172/JCI115330.
110. Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K., and Takizawa, H. (2003). Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int. Arch. Allergy Immunol. 132, 168-176. doi: 10.1159/000073718.
111. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., et al. (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490. doi: 10.1016/j.immuni.2005.09.015.
112. Shindoh, Y., Tanno, Y., Ida, S., and Takishima, T. (1987). Morphological characterization of basophilic cells in bronchoalveolar lavage fluids from patients with bronchial asthma and idiopathic pulmonary fibrosis. Tohoku J. Exp. Med. 152, 101-102. doi: 10.1620/tjem.152.101.
113. Shiota, N., Nishikori, Y., Kakizoe, E., Shimoura, K., Niibayashi, T., Shimbori, C., et al. (2010). Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice. Int. Arch. Allergy Immunol. 151, 80-88. doi: 10.1159/000232573.
114. Silver, R. B. (2013). Role of mast cells in renal fibrosis. Kidney Int. 84, 214. doi: 10.1038/ki.2013.72.
115. Smith, T. J., and Parikh, S. J. (1999). HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis. Endocrinology 140, 3518-3525. doi: 10.1210/en.140.8.3518.
116. Stevens, R. L., and Adachi, R. (2007). Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity. Immunol. Rev. 217, 155-167. doi: 10.1111/j.1600-065X.2007.00525.x.
117. Stock, M. K., Hammerich, L., do O, N. T., Berres, M. L., Alsamman, M., Heinrichs, D., et al. (2013). Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression. Int. J. Clin. Exp. Pathol. 6, 678-685.
118. Stramer, B. M., Mori, R., and Martin, P. (2007). The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J. Invest. Dermatol. 127, 1009-1017. doi: 10.1038/sj.jid.5700811.
119. Summers, S. A., Gan, P. Y., Dewage, L., Ma, F. T., Ooi, J. D., O'Sullivan, K. M., et al. (2012). Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int. 82, 676-685. doi: 10.1038/ki.2012.211.
120. Takato, H., Yasui, M., Ichikawa, Y., Waseda, Y., Inuzuka, K., Nishizawa, Y., et al. (2011). The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice. Exp. Lung Res. 37, 101-108. doi: 10.3109/01902148.2010.520815.
121. Tchougounova, E., Lundequist, A., Fajardo, I., Winberg, J. O., Abrink, M., and Pejler, G. (2005). A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280, 9291-9296. doi: 10.1074/jbc.M410396200.
122. Toth, T., Toth-Jakatics, R., Jimi, S., and Takebayashi, S. (2000). Increased density of interstitial mast cells in amyloid A renal amyloidosis. Mod. Pathol. 13, 1020-1028. doi: 10.1038/modpathol.3880184.
123. Trautmann, A., Toksoy, A., Engelhardt, E., Brocker, E. B., and Gillitzer, R. (2000). Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J. Pathol. 190, 100-106. doi: 10.1002/(SICI)1096-9896(200001)190:1<100::AID-PATH496>3.0.CO;2-Q.
124. Varadaradjalou, S., Feger, F., Thieblemont, N., Hamouda, N. B., Pleau, J. M., Dy, M., et al. (2003). Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33, 899-906. doi: 10.1002/eji.200323830.
125. Veerappan, A., O'Connor, N. J., Brazin, J., Reid, A. C., Jung, A., McGee, D., et al. (2013). Mast cells: a pivotal role in pulmonary fibrosis. DNA Cell Biol. 32, 206-218. doi: 10.1089/dna.2013.2005.
126. Veerappan, A., Reid, A. C., O'Connor, N., Mora, R., Brazin, J. A., Estephan, R., et al. (2012). Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am. J. Physiol. Renal Physiol. 302, F192-F204. doi: 10.1152/ajprenal.00562.2010.
127. Voehringer, D. (2013). Protective and pathological roles of mast cells and basophils. Nat. Rev. Immunol. 13, 362-375. doi: 10.1038/nri3427.
128. Welle, M. (1997). Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61, 233-245.
129. Weller, K., Foitzik, K., Paus, R., Syska, W., and Maurer, M. (2006). Mast cells are required for normal healing of skin wounds in mice. FASEB J. 20, 2366-2368. doi: 10.1096/fj.06-5837fje.
130. Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., et al. (2005). Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166, 1321-332. doi: 10.1016/S0002-9440(10)62351-6.
131. Wilson, M. S., and Wynn, T. A. (2009). Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2, 103-121. doi: 10.1038/mi.2008.85.
132. Wulff, B. C., and Wilgus, T. A. (2013). Mast cell activity in the healing wound: more than meets the eye? Exp. Dermatol. 22, 507-510. doi: 10.1111/exd.12169.
133. Wygrecka, M., Kwapiszewska, G., Jablonska, E., von Gerlach, S., Henneke, I., Zakrzewicz, D., et al. (2013). Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183, 1703-1714. doi: 10.1164/rccm.201009-1479OC.
134. Wynn, T. A. (2011). Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208, 1339-1350. doi: 10.1084/jem.20110551.
135. Younan, G. J., Heit, Y. I., Dastouri, P., Kekhia, H., Xing, W., Gurish, M. F., et al. (2011). Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast. Reconstr. Surg. 128, 649e-658e. doi: 10.1097/PRS.0b013e318230c55d.
136. Zucker-Franklin, D. (1980). Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 56, 534-540.